Heart Disease Trial, Recruiting (NCT06471036)

Heart Disease Trial, Recruiting NCT06471036 Sponsor: Duke University Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06471036 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You were admitted to the hospital with a specific type of heart attack (called NSTEMI Type 1 or STEMI) and/or had a procedure to open blocked heart arteries (such as a stent)
Your LDL ("bad") cholesterol level was 70 mg/dL or higher during your hospital stay
You have a primary care doctor and/or heart specialist who works within the same health system and uses the same medical records system, who will continue to see you after you leave the hospital

Who may not be able to join:

You are considered unlikely to survive or continue follow-up care within the same health system for at least 6 months — for example, if you are receiving hospice care or have significant memory loss/dementia (confirm with trial site)
You had open-heart bypass surgery (called CABG) during your hospital stay, meaning you would be discharged from a surgical unit rather than a cardiology unit

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 919 668 8742

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06471036

Sponsor: Duke University

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: 919 668 8742

More information: https://clinicaltrials.gov/study/NCT06471036

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You were admitted to the hospital with a specific type of heart attack (called NSTEMI Type 1 or STEMI) and/or had a procedure to open blocked heart arteries (such as a stent)
Your LDL ("bad") cholesterol level was 70 mg/dL or higher during your hospital stay
You have a primary care doctor and/or heart specialist who works within the same health system and uses the same medical records system, who will continue to see you after you leave the hospital

Who may not be able to join:

You are considered unlikely to survive or continue follow-up care within the same health system for at least 6 months — for example, if you are receiving hospice care or have significant memory loss/dementia (confirm with trial site)
You had open-heart bypass surgery (called CABG) during your hospital stay, meaning you would be discharged from a surgical unit rather than a cardiology unit

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Duke University

Registry

ClinicalTrials.gov

Start date

8 October 2024

Est. completion

30 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Within-patient change in LDL-C (low-density lipoprotein cholesterol) from baseline (during admission) to last LDL-C level checked within 6+2 (8) months post-discharge

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov